NCT03221205View on ClinicalTrials.gov

Effect of CPAP on Myocardial Dysfunction in Type 2 Diabetes Mellitus and Obstructive Sleep Apnea Patients

NACompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

October 15, 2014

Primary Completion Date

October 24, 2017

Study Completion Date

November 24, 2017

Conditions
Sleep Apnea, ObstructiveDiabetes Mellitus, Type 2Continuous Positive Airway PressureMyocardial DysfunctionEchocardiographyObesity
Interventions
DEVICE

Sham CPAP

CPAP (ResMed AutoSet S9 with humidifier) to be used by the participant via nasal mask and tube, programmed to apply 0.5 cmH2O (measured at the nasal mask) via a resistance to assure the lack of distal pressure.

DEVICE

Therapeutic CPAP

Use of CPAP (ResMed AutoSet S9 with humidifier) through nasal mask and tube with automatized pressure from 4 to 20 cmH2O.

Trial Locations (1)

14080

Insituto Nacional de Enfermedades Respiratorias, Mexico City

All Listed Sponsors
collaborator

Fundación Clínica Médica Sur

OTHER

collaborator

National Council of Science and Technology, Mexico

OTHER

lead

Instituto Nacional de Enfermedades Respiratorias

OTHER_GOV

NCT03221205 - Effect of CPAP on Myocardial Dysfunction in Type 2 Diabetes Mellitus and Obstructive Sleep Apnea Patients | Biotech Hunter | Biotech Hunter